GO:0009165 nucleotide biosynthetic process: Metabolic Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0009165 nucleotide biosynthetic process describes all chemical reactions and pathways that build nucleotides, the phosphorylated nucleosides that serve as RNA/DNA building blocks and signaling molecules.
• Nucleotide biosynthesis is a pan-cancer metabolic dependency, making it a central target for oncology research and drug development.
• The pathway is tightly regulated and integrated with epigenetics, as nucleotide availability influences DNA and histone methylation.
• Key enzymes include purine and pyrimidine biosynthetic proteins such as CAD, GART, IMPDH, and UMPS, which are frequently studied using CRISPR knockout and knock-in models.
• Defects in nucleotide salvage and biosynthesis are linked to neurodegeneration and DNA damage sensitivity.
• Studying GO:0009165 requires integrated methods such as metabolomics, CRISPR screening, and transcriptomics to resolve pathway flux and gene function.
Description
Nucleotide biosynthetic process (GO:0009165) encompasses the chemical reactions and pathways that result in the formation of nucleotides, which are nucleosides esterified with phosphate groups at any hydroxyl group of the sugar moiety, including mono-, di-, and triphosphates as well as cyclic nucleotides. This process is fundamental to all living systems because nucleotides are the monomeric units of RNA and DNA, carriers of chemical energy (e.g., ATP, GTP), and components of essential coenzymes such as NAD, FAD, and coenzyme A. In rapidly proliferating cells, nucleotide biosynthesis must be upregulated to meet the demands of genome replication and biomass production, and its dysregulation is a hallmark of many cancers. Consequently, researchers across cancer biology, immunology, and neurobiology study this pathway to identify therapeutic vulnerabilities and understand basic cell physiology. The pathway is also intimately linked to epigenetic regulation, as the availability of nucleotide cofactors like S-adenosylmethionine (SAM) and acetyl-CoA influences chromatin modifications. Moreover, nucleotide metabolism is compartmentalized, with distinct enzymes and transport systems operating in the cytosol, mitochondria, and other organelles, adding layers of complexity that require sophisticated experimental models. This article provides a comprehensive overview of GO:0009165, covering its definition, biological significance, key genes, regulatory mechanisms, disease associations, and state-of-the-art research methods, with a focus on how CRISPR-based tools can be applied to dissect this essential process.
nucleotide biosynthetic process At A Glance
| GO ID | GO:0009165 |
|---|---|
| GO term | nucleotide biosynthetic process |
| Ontology | biological_process |
| Synonym | nucleotide anabolism, nucleotide biosynthesis, nucleotide formation, nucleotide synthesis |
| Major function | Synthesis of nucleotides (purine and pyrimidine) for DNA/RNA, energy carriers, and coenzymes |
| Definition | The chemical reactions and pathways resulting in the formation of nucleotides, any nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the glycose moiety; may be mono-, di- or triphosphate; this definition includes cyclic-nucleotides (nucleoside cyclic phosphates). |
| Related pathways | De novo purine biosynthesis, de novo pyrimidine biosynthesis, salvage pathways, nucleotide sugar metabolism |
| Compartment | Cytosol, mitochondria, nucleus (varies by enzyme and organism) |
What Is GO:0009165?
According to the Gene Ontology, nucleotide biosynthetic process (GO:0009165) is defined as the chemical reactions and pathways resulting in the formation of nucleotides, any nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the glycose moiety; may be mono-, di- or triphosphate; this definition includes cyclic-nucleotides (nucleoside cyclic phosphates). In simpler terms, it covers all the enzymatic steps that build nucleotides from simpler precursors, whether through de novo synthesis from small molecules like amino acids and sugars or through salvage pathways that recycle preformed nucleobases and nucleosides. The term is a biological process and encompasses both purine and pyrimidine nucleotide biosynthesis, as well as the formation of nucleotide sugars and cyclic nucleotides.
Why Is nucleotide biosynthetic process Important in Cell Biology?
Nucleotide biosynthetic process is essential for cell proliferation, survival, and function, as it provides the building blocks for nucleic acids and the cofactors required for energy metabolism and signaling. Its upregulation is a metabolic hallmark of cancer, and targeting this pathway has yielded successful chemotherapies such as methotrexate and 5-fluorouracil. Beyond cancer, defects in nucleotide metabolism cause severe disorders including neurodegeneration, mitochondrial diseases, and immunodeficiencies. The pathway also intersects with epigenetics, as nucleotide coenzymes like SAM and acetyl-CoA are substrates for chromatin-modifying enzymes, thereby influencing gene expression. Understanding the regulation and vulnerabilities of nucleotide biosynthesis is therefore critical for developing new therapeutic strategies and for interpreting disease mechanisms.
• Provides the building blocks for DNA and RNA synthesis, essential for cell division and growth.
• Supports energy metabolism through ATP and GTP production and coenzymes like NAD and FAD.
• Is a pan-cancer metabolic dependency, offering targets for chemotherapy and precision oncology.
• Links to epigenetics via nucleotide cofactors that drive DNA and histone methylation.
• Defects in salvage and biosynthesis cause neurodegeneration and DNA damage sensitivity.
• Mitochondrial nucleotide transport and metabolism are critical for organellar genome maintenance.
• Nucleotide sugars are required for glycosylation and cell wall biosynthesis in various organisms.
• Diatom nucleotide metabolism reveals ecological and evolutionary adaptations.
• Regulation by mTOR and other signaling pathways integrates nutrient status with nucleotide production.
• CRISPR screens have identified nucleotide biosynthetic enzymes as essential genes in many cell types.
What Happens During nucleotide biosynthetic process?
De Novo Purine Biosynthesis
In simple terms: The cell builds purine rings from scratch using small molecules like amino acids and sugars.
De novo purine biosynthesis converts phosphoribosyl pyrophosphate (PRPP) into inosine monophosphate (IMP) through a series of ten enzymatic steps, utilizing glycine, glutamine, aspartate, and formyl-THF as nitrogen and carbon donors. Key enzymes include GART, PFAS, PAICS, ADSL, and ATIC, which form a multienzyme complex called the purinosome in the cytosol. IMP is then converted to AMP and GMP via separate branches, with IMPDH catalyzing the rate-limiting step for GMP synthesis. This pathway is highly energy-intensive and is tightly regulated by feedback inhibition and transcriptional control.
De Novo Pyrimidine Biosynthesis
In simple terms: The cell assembles pyrimidine rings step by step, starting with carbamoyl phosphate and aspartate.
De novo pyrimidine biosynthesis begins with the formation of carbamoyl phosphate by CPS2, which is then condensed with aspartate by CAD (carbamoyl-phosphate synthetase 2, aspartate transcarbamoylase, dihydroorotase) to form dihydroorotate. Subsequent steps catalyzed by DHODH, UMPS, and CTP synthase yield UMP, which is phosphorylated to UTP and CTP. The pathway is regulated by allosteric feedback from UTP and CTP and is spatially organized, with CAD and DHODH associated with mitochondria. Pyrimidine biosynthesis is essential for RNA and DNA synthesis and for the formation of nucleotide sugars.
Salvage Pathways
In simple terms: Instead of building from scratch, cells can recycle preformed nucleobases and nucleosides from degraded nucleic acids or diet.
Salvage pathways recover purines and pyrimidines by converting free bases or nucleosides back into nucleotides, using enzymes such as HPRT1, APRT, and TK1. These pathways are energetically cheaper than de novo synthesis and are particularly important in tissues with low biosynthetic capacity, such as the brain. Deficiencies in salvage enzymes like HPRT1 cause Lesch-Nyhan syndrome, highlighting their physiological importance. Salvage also plays a role in drug activation, as nucleoside analogs used in chemotherapy and antiviral therapy rely on salvage kinases.
Nucleotide Sugar and Cyclic Nucleotide Formation
In simple terms: Nucleotides can be further modified to create sugars used in glycosylation or cyclic signals like cAMP.
Nucleotide sugars are formed by attaching sugars to nucleotides, such as UDP-glucose and GDP-mannose, which are essential for glycosylation of proteins and lipids and for cell wall biosynthesis in plants and microbes. Cyclic nucleotides, including cAMP and cGMP, are synthesized from ATP and GTP by adenylyl and guanylyl cyclases, respectively, and serve as second messengers in signal transduction. These derivatives expand the functional repertoire of nucleotides beyond nucleic acid synthesis.
Compartmentalization and Transport
In simple terms: Nucleotide synthesis happens in different parts of the cell, and nucleotides must be moved between compartments.
Nucleotide biosynthesis is compartmentalized: purine de novo synthesis occurs in the cytosol, while pyrimidine biosynthesis is partially mitochondrial due to DHODH's location on the inner mitochondrial membrane. Mitochondria also contain their own nucleotide salvage and transport systems, including carriers like SLC25A33 and SLC25A36, to supply nucleotides for mitochondrial DNA replication and RNA synthesis. In diatoms, nucleotide transport and metabolism show unique adaptations to their ecological niches. Proper compartmentalization ensures that nucleotide pools are balanced across organelles.
Key Genes Involved in GO:0009165 nucleotide biosynthetic process
The following genes encode key enzymes and regulators of nucleotide biosynthetic process, representing major nodes for experimental interrogation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CAD | Trifunctional enzyme catalyzing the first three steps of pyrimidine biosynthesis | Target for cancer therapy; knockout causes pyrimidine auxotrophy |
| DHODH | Mitochondrial enzyme catalyzing the fourth step of pyrimidine biosynthesis | Inhibitor target in leukemia; links pyrimidine synthesis to mitochondrial respiration |
| UMPS | Converts orotate to UMP in pyrimidine biosynthesis | Deficiency causes orotic aciduria; target for 5-FU activation |
| CTPS1/2 | Synthesizes CTP from UTP, essential for RNA and DNA synthesis | CTPS1 mutations cause immunodeficiency; CTPS2 less studied |
| GART | Trifunctional enzyme in purine biosynthesis (GAR synthetase, GAR transformylase, AIR synthetase) | Part of purinosome; knockout leads to purine auxotrophy |
| PFAS | Phosphoribosylformylglycinamidine synthase in purine biosynthesis | Essential for de novo purine synthesis; potential cancer target |
| PAICS | Bifunctional enzyme in purine biosynthesis (AIR carboxylase, SAICAR synthetase) | Overexpressed in cancers; involved in purinosome assembly |
| ADSL | Adenylosuccinate lyase in purine biosynthesis | Deficiency causes adenylosuccinate lyase deficiency, a neurodevelopmental disorder |
| ATIC | Bifunctional enzyme in purine biosynthesis (AICAR transformylase, IMP cyclohydrolase) | Target of antifolates; part of purinosome |
| IMPDH1/2 | Catalyzes rate-limiting step of GMP synthesis from IMP | Inhibitors used as immunosuppressants and antivirals; knockout affects guanine nucleotide pools |
| GMPS | Converts XMP to GMP in purine biosynthesis | Potential target in cancer; links to guanine nucleotide supply |
| HPRT1 | Salvage enzyme converting hypoxanthine to IMP | Deficiency causes Lesch-Nyhan syndrome; model for neurodegeneration |
| APRT | Salvage enzyme converting adenine to AMP | Deficiency causes 2,8-dihydroxyadenine urolithiasis; model for purine salvage |
| TK1 | Salvage enzyme phosphorylating thymidine to TMP | Marker of cell proliferation; target for nucleoside analogs |
| PRPS1 | Synthesizes PRPP, a precursor for both purine and pyrimidine biosynthesis | Mutations cause PRPS1 superactivity and Arts syndrome; key regulatory node |
| MTHFD2 | Mitochondrial enzyme in one-carbon metabolism supplying purine synthesis | Overexpressed in cancer; links metabolism to epigenetics |
| SHMT2 | Serine hydroxymethyltransferase providing one-carbon units for purine synthesis | Essential in cancer; knockout reduces purine synthesis |
| SLC25A33 | Mitochondrial pyrimidine nucleotide carrier | Regulates mitochondrial nucleotide pools; knockout affects mtDNA maintenance |
How Is nucleotide biosynthetic process Regulated?
Nucleotide biosynthetic process is regulated at multiple levels to match cellular demand. The mTOR signaling pathway promotes nucleotide synthesis by activating transcription factors such as ATF4 and MYC, which induce expression of biosynthetic enzymes. Allosteric feedback inhibition by end products (e.g., UTP, CTP, GMP, AMP) controls flux through key enzymes like CAD, IMPDH, and PRPS1. Post-translational modifications, including phosphorylation and ubiquitination, modulate enzyme activity and stability. The pathway is also integrated with one-carbon metabolism, as folate cycle enzymes supply formyl groups for purine synthesis, and with epigenetics through SAM availability. In mitochondria, nucleotide transport and metabolism are regulated by specific carriers and by the demand for mtDNA replication. Additionally, the integrated stress response can reprogram nucleotide metabolism under stress conditions.
nucleotide biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HPRT1 | Lesch-Nyhan syndrome, hyperuricemia, neurodegeneration | HPRT1 knockout iPSCs or mice for studying purine salvage and neuronal dysfunction |
| ADSL | Adenylosuccinate lyase deficiency, neurodevelopmental disorder | ADSL knockout cell lines and patient-derived fibroblasts to study purine imbalance |
| CTPS1 | Immunodeficiency, impaired lymphocyte proliferation | CTPS1 knockout T cells or organoids to model immune defects |
| DHODH | Cancer, mitochondrial dysfunction | DHODH knockout or inhibitor-treated cancer cell lines to assess pyrimidine dependency |
| SLC25A33 | Mitochondrial DNA depletion syndrome | SLC25A33 knockout cells to study mitochondrial nucleotide transport |
Cancer
Nucleotide biosynthetic process is a pan-cancer metabolic dependency, as many tumors upregulate de novo synthesis to support rapid proliferation. Oncogenes such as MYC and mutant KRAS drive expression of nucleotide biosynthetic enzymes, while tumor suppressors like p53 can modulate pathway activity. Inhibitors of enzymes such as DHODH, IMPDH, and CAD have shown efficacy in preclinical and clinical studies, and CRISPR screens have identified these genes as essential in various cancer cell lines. Targeting nucleotide synthesis can also overcome chemoresistance and synergize with immunotherapy.
Neurodegeneration
Defects in nucleotide salvage and biosynthesis cause neurodegeneration, as neurons rely heavily on salvage pathways due to low de novo synthesis. HPRT1 deficiency leads to Lesch-Nyhan syndrome, characterized by neurological dysfunction, while APRT deficiency causes kidney stones and can affect the nervous system. Mutations in ADSL cause adenylosuccinate lyase deficiency, a neurodevelopmental disorder with epilepsy and autism. Additionally, DNA damage from nucleotide imbalance contributes to neuronal death, linking nucleotide metabolism to aging and neurodegenerative diseases.
Mitochondrial Diseases
Mitochondrial nucleotide transport and metabolism are essential for mtDNA maintenance, and defects cause mitochondrial diseases. Mutations in SLC25A33 or other mitochondrial carriers impair pyrimidine nucleotide supply, leading to mtDNA depletion syndromes. DHODH, located in mitochondria, links pyrimidine synthesis to respiratory chain function, and its inhibition can cause mitochondrial dysfunction. Understanding these pathways is critical for diagnosing and treating mitochondrial disorders.
Immunodeficiencies and Epigenetic Disorders
CTPS1 deficiency causes severe immunodeficiency due to impaired CTP synthesis, affecting lymphocyte proliferation. Nucleotide metabolism also influences epigenetics by regulating SAM and acetyl-CoA levels, thereby impacting DNA and histone methylation. Dysregulation of one-carbon metabolism enzymes like MTHFD2 and SHMT2 alters the epigenetic landscape and contributes to cancer and developmental disorders. These connections highlight the broad physiological impact of nucleotide biosynthesis.
From nucleotide biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a nucleotide biosynthetic gene essential for cancer cell proliferation? | CRISPR knockout in cancer cell lines followed by viability assays |
| Does a specific point mutation in an enzyme alter its catalytic activity? | CRISPR point mutation knock-in in isogenic cell lines |
| How does a gene fusion affect nucleotide metabolism? | CRISPR knock-in of tagged fusion protein for localization and interaction studies |
| What is the effect of gene overexpression on nucleotide pools? | CRISPR overexpression via safe-harbor knock-in of the gene of interest |
| Which genes are required for nucleotide synthesis under stress? | Genome-wide CRISPR library screening with metabolomic readouts |
| How does a disease-associated mutation affect pathway flux? | Patient-derived iPSCs with CRISPR correction or introduction of the mutation |
How to Study the nucleotide biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS metabolomics | Steady-state levels of nucleotides and intermediates | Quantifying pathway output in knockout cells |
| 13C/15N isotope tracing | Flux through biosynthetic pathways | Determining de novo vs salvage contribution |
| CRISPR knockout screens | Gene essentiality and fitness effects | Identifying nucleotide synthesis dependencies in cancer |
| RNA-seq | Transcriptional changes in pathway genes | Assessing regulation by oncogenes or stress |
| Proteomics | Protein abundance and modifications | Detecting enzyme expression and post-translational regulation |
| Fluorescence microscopy | Subcellular localization and complex formation | Visualizing purinosome assembly |
| Biosensor imaging | Real-time nucleotide dynamics (e.g., cAMP, ATP) | Monitoring signaling and energy status |
| CRISPR point mutation knock-in | Effect of specific mutations on enzyme function | Modeling disease-associated variants |
Metabolomics and Flux Analysis
Metabolomics using mass spectrometry quantifies nucleotide pools and isotope tracing reveals flux through de novo and salvage pathways. These methods are essential for assessing how genetic perturbations affect nucleotide biosynthesis and for identifying metabolic vulnerabilities.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens can identify genes required for nucleotide biosynthesis and uncover synthetic lethal interactions. Screens coupled with metabolomic profiling or drug sensitivity provide functional annotations for uncharacterized enzymes.
Transcriptomics and Proteomics
RNA-seq and proteomics measure expression changes in nucleotide biosynthetic enzymes under different conditions, revealing transcriptional and post-transcriptional regulation. Phosphoproteomics can identify signaling events that control enzyme activity.
Imaging and Subcellular Localization
Fluorescence microscopy of tagged enzymes (e.g., GFP knock-in) visualizes purinosome formation and mitochondrial association of pyrimidine enzymes. Live-cell imaging with biosensors can monitor nucleotide dynamics in real time.
How CRISPR Can Be Used to Study GO:0009165 nucleotide biosynthetic process
Knockout
CRISPR knockout of nucleotide biosynthetic genes (e.g., CAD, DHODH, IMPDH) creates auxotrophic cell lines that require exogenous nucleosides for growth, enabling studies of pathway dependency and drug resistance. Knockout models also reveal compensatory salvage mechanisms and are used in synthetic lethality screens.
Point Mutation
CRISPR point mutation knock-in introduces specific amino acid substitutions found in patients or acquired under drug selection, allowing functional analysis of enzyme variants. For example, mutations in IMPDH confer resistance to inhibitors, and modeling them helps understand drug binding and resistance mechanisms.
Knock-in
Knock-in of tagged versions (e.g., GFP, HA) of nucleotide enzymes enables live-cell imaging, immunoprecipitation, and proteomic studies to determine localization and interaction partners. Knock-in of reporter cassettes can also monitor pathway activity through fluorescent or luminescent readouts.
Overexpression
CRISPR-mediated overexpression via safe-harbor integration or activation of endogenous loci increases enzyme levels to study pathway flux, metabolite pool expansion, and oncogenic potential. Overexpression models are useful for testing whether a gene is sufficient to drive proliferation or drug resistance.
How EDITGENE Supports nucleotide biosynthetic process Research
Researchers studying nucleotide biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in pathway regulation, disease progression, or drug response. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional interrogation of nucleotide metabolism.
Contact EDITGENE today to design your custom CRISPR model for nucleotide biosynthetic process research.
Frequently Asked Questions About nucleotide biosynthetic process
What is nucleotide biosynthetic process?
Nucleotide biosynthetic process (GO:0009165) is the set of chemical reactions and pathways that build nucleotides, the phosphorylated nucleosides that serve as building blocks of DNA and RNA and as energy carriers and signaling molecules.
What genes are involved in nucleotide biosynthetic process?
Key genes include CAD, DHODH, UMPS, CTPS1/2 for pyrimidine synthesis; GART, PFAS, PAICS, ADSL, ATIC, IMPDH1/2, GMPS for purine synthesis; and salvage genes like HPRT1, APRT, and TK1.
Why is nucleotide biosynthesis important for cancer?
Many cancers upregulate nucleotide biosynthesis to support rapid proliferation, making it a metabolic dependency and a target for therapies such as methotrexate and 5-fluorouracil.
How is nucleotide biosynthetic process regulated?
It is regulated by mTOR signaling, allosteric feedback inhibition by end products, transcriptional control by MYC and ATF4, and integration with one-carbon metabolism and epigenetics.
What diseases are linked to defects in nucleotide metabolism?
Defects cause Lesch-Nyhan syndrome, adenylosuccinate lyase deficiency, immunodeficiencies, mitochondrial DNA depletion syndromes, and neurodegeneration.
What methods are used to study nucleotide biosynthesis?
Common methods include LC-MS metabolomics, isotope tracing, CRISPR screens, RNA-seq, proteomics, and fluorescence imaging of tagged enzymes.
How can CRISPR be used to study nucleotide biosynthetic genes?
CRISPR knockout, point mutation knock-in, tagged knock-in, and overexpression enable functional analysis of gene essentiality, enzyme activity, localization, and drug resistance.
What is the role of mitochondria in nucleotide biosynthesis?
Mitochondria host key steps of pyrimidine synthesis (DHODH) and have specific nucleotide transporters (e.g., SLC25A33) that supply nucleotides for mtDNA maintenance.
Are nucleotide sugars part of nucleotide biosynthetic process?
Yes, the formation of nucleotide sugars such as UDP-glucose is included in GO:0009165, as they are nucleotides modified with sugars for glycosylation.
How does nucleotide metabolism influence epigenetics?
Nucleotide metabolism provides cofactors like SAM and acetyl-CoA that are substrates for DNA and histone modifying enzymes, thereby impacting gene expression.
Conclusion
Nucleotide biosynthetic process (GO:0009165) is a fundamental biological pathway that supplies the building blocks for nucleic acids, energy carriers, and signaling molecules. Its dysregulation is implicated in cancer, neurodegeneration, mitochondrial diseases, and immunodeficiencies, making it a rich area for therapeutic development. Advances in CRISPR-based models, metabolomics, and screening technologies are enabling researchers to dissect the pathway with unprecedented precision. EDITGENE's comprehensive services support these efforts by providing custom-engineered cell models and bioinformatics solutions, empowering discoveries that translate into clinical impact.
References
- 1. Mullen NJ et al.. 2023. Nucleotide metabolism: a pan-cancer metabolic dependency.. Nat Rev Cancer 23(5):275-294 PMID: 36973407
- 2. Lane AN et al.. 2015. Regulation of mammalian nucleotide metabolism and biosynthesis.. Nucleic Acids Res 43(4):2466-85 PMID: 25628363
- 3. Suganuma T et al.. 2021. Nucleotide Metabolism Behind Epigenetics.. Front Endocrinol (Lausanne) 12:731648 PMID: 34526971
- 4. Veech RL et al.. 2019. The "great" controlling nucleotide coenzymes.. IUBMB Life 71(5):565-579 PMID: 30624851
- 5. Gruber A et al.. 2019. Nucleotide Transport and Metabolism in Diatoms.. Biomolecules 9(12) PMID: 31766535
- 6. Mikkola S. 2020. Nucleotide Sugars in Chemistry and Biology.. Molecules 25(23) PMID: 33291296
- 7. MacVicar T. 2025. High tide or low tide: the transport and metabolism of mitochondrial nucleotides.. Biochem J 482(16):1105-22 PMID: 40824221
- 8. Fasullo M et al.. 2015. Nucleotide salvage deficiencies, DNA damage and neurodegeneration.. Int J Mol Sci 16(5):9431-49 PMID: 25923076
